Andrew Dreyfus - 01 Feb 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Director
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Issuer symbol
ANRO
Transactions as of
01 Feb 2024
Net transactions value
$0
Form type
4
Filing time
05 Feb 2024, 16:40:49 UTC
Previous filing
22 Jun 2023
Next filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Stock Option (right to buy) Award $0 +30,574 $0.000000 30,574 01 Feb 2024 Common Stock 30,574 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date.